NCT05389865

Brief Summary

The aorta is the principal arterial vessel arising from the left heart that transfers blood to the body. Certain genetic and familial disease processes are known to weaken the aortic wall resulting in dilation and potential rupture. These aortic complications carry high mortality (\>25%) and current management is orientated towards early detection and preventive treatment. Aortic dilation can also result in aortic valve dysfunction leading to heart failure. The estimated UK incidence of aortic disease per year is around 10 per 100,000 individuals, with 2000 people per year dying from aortic complications. The 2017-2020 National Adult Cardiac Surgery Audit report identified the number of people receiving surgery for aortic dissection in Scotland is per population proportionately lower compared to England (4.6 per million per year in Scotland vs. 6.6 per million per year in England). The reasons for this are unclear but may relate to the prevalence of aortic disease or a large geographic distribution with compromised access to specialized centres. Currently surgery is recommended when the aortic diameter exceeds a certain threshold. There are several types of effective surgical procedures, but there is still limited information on their long-term outcomes and the advantage of one procedure over another. The aims of the project are firstly to determine the clinical outcomes of the surgical procedures that are currently employed in Scotland to treat proximal aortic disease and secondly to describe the prevalence and distribution of proximal aortic disease within the Scottish population. The project will be hosted by the Golden Jubilee Research Institute. Contemporary and retrospective data will be collected from all the Scottish Cardiothoracic Surgery units which are based in Glasgow, Edinburgh and Aberdeen. This will be the first study to analyse surgical outcomes for ascending aortic disease in Scotland, and the first to describe the epidemiology of aortic disease within the population. It is anticipated that the results will guide current surgical practise, and provide data to inform national service provision for the management of proximal aortic disease.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,662

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
1.6 years until next milestone

Study Start

First participant enrolled

December 18, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

1.6 years

First QC Date

May 6, 2022

Last Update Submit

July 11, 2024

Conditions

Keywords

aortic surgeryaortic rootascending aortasurgical outcomesthoracic aortopathy epidemiology

Outcome Measures

Primary Outcomes (3)

  • Early survival following surgery of the proximal aorta

    In-hospital or 30 days survival following surgery of the proximal aorta

    In-hospital or 30 days (whichever is longer)

  • Late survival following surgery of the proximal aorta

    Long-term survival following surgery of the proximal aorta

    5 years or latest available follow-up (whichever is longer)

  • Patient demographics and geographic distribution of thoracic aortopathy within the Scottish population

    Identify the demographics (age, gender, relevant risk factors) and geographic distribution (area codes) of patients diagnosed with thoracic aortopathy within the Scottish population

    Cross-sectional analysis (2011-2021)

Secondary Outcomes (5)

  • Cardiovascular reintervention

    1 year or latest available follow-up (whichever is longer)

  • Specified adverse events following surgery

    1 year or latest available follow-up (whichever is longer)

  • Left ventricular ejection fraction (LVEF) following surgery

    1 year or latest available follow-up (whichever is longer)

  • Aortic valve mean gradient and degree of regurgitation following surgery

    1 year or latest available follow-up (whichever is longer)

  • Genotypes and phenotypes prevalent in the Scottish population

    Previous 5 years

Study Arms (2)

Surgical cohort

Adult patients (18 years of age and above) who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen.

Procedure: Surgery on the proximal aorta (aortic root +/- ascending aorta)

Non-surgical cohort

\- Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources: 1. Scottish national radiological database based on specific imaging codes 2. Regional genetic/inherited cardiac conditions services 3. Public Health Scotland via specific diagnostic ICD-10 codes.

Other: Patients diagnosed with thoracic aortopathy but not operated upon

Interventions

Surgery involving replacing, repairing or reinforcing the proximal aorta (root and ascending aorta)

Surgical cohort

Radiological size criteria or Genetic mutations associated with aortopathies

Non-surgical cohort

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. Surgical cohort (Observational cohort design)- Adult patients (18 years of age and above) who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen. 2. Non-surgical cohort (Cross-sectional design) - Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources: 1. Scottish national radiological database based on specific imaging codes 2. Regional genetic/inherited cardiac conditions services 3. Public Health Scotland via specific diagnostic ICD-10 codes.

You may qualify if:

  • all adults (\>18 years of age) that underwent surgical intervention on the proximal aorta in Scotland between 2008 and 2021.

You may not qualify if:

  • Isolated surgery on the descending thoracic aorta
  • Non-surgical cohort
  • \- all adult patients (\>18 years of age) with a radiological, genetic or post-mortem diagnosis of thoracic aortic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Golden Jubilee National Hospital

Glasgow, United Kingdom

Location

MeSH Terms

Conditions

Aortic DiseasesAortic DissectionAortic Aneurysm, ThoracicAortic Valve InsufficiencyBicuspid Aortic Valve DiseaseMarfan SyndromeEhlers-Danlos SyndromeLoeys-Dietz Syndrome

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesDissection, Blood VesselAneurysmAcute Aortic SyndromeAortic AneurysmAortic Valve DiseaseHeart Valve DiseasesHeart DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesAbnormalities, MultipleGenetic Diseases, InbornConnective Tissue DiseasesSkin and Connective Tissue DiseasesHemostatic DisordersHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesSkin AbnormalitiesSkin Diseases, GeneticCollagen DiseasesSkin DiseasesCraniofacial AbnormalitiesMusculoskeletal Abnormalities

Study Officials

  • George Gradinariu, MD

    Golden Jubilee National Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Cardiothoracic Surgery Specialty Registrar

Study Record Dates

First Submitted

May 6, 2022

First Posted

May 25, 2022

Study Start

December 18, 2023

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

July 15, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

To apply for further studies, beyond the current research, using the existing dataset, a research proposal submitted to the GJNH Research Department will be required. This will follow the established internal peer-review process established by the GJNH research department. If approved, a data request form will need to be submitted to the data custodian who will release the pseudo- anonymised data to the research applicant. If there is no request to extend the study then this data will be deleted.

Locations